-transparent.png){kind=logo}
Plasma terbutaline levels and peak expiratory flow rates were measured in 5 asthmatic children using doses of 0.25 and 0.075 mg/kg. The higher dose resulted in safe, non-toxic plasma levels and returned the peak expiratory flow rate to normal. This dose (maximum 5 mg) is safe in children.
Related Publications
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
August 1983,
Archives of disease in childhood,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
January 1991,
Pulmonary pharmacology,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
October 1985,
European journal of respiratory diseases,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
September 1975,
The Medical letter on drugs and therapeutics,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
January 1984,
European journal of respiratory diseases. Supplement,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
April 1985,
Clinical pharmacology and therapeutics,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
March 1995,
American journal of respiratory and critical care medicine,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
March 1973,
Archives of disease in childhood,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
December 1991,
Archives of disease in childhood,
R Dinwiddie, and
M Gewitz, and
H Van der Laag, and
M H Frame
April 1981,
Thorax,
